Labeler
Biocon Pharma Inc. NDC Codes
Biocon Pharma Inc. lists 88 finished drug products in the FDA NDC Directory under NDC labeler code 70377.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Everolimus, Lenalidomide, Dasatinib, Simvastatin, Eltrombopag, Labetalol Hydrochloride, Mycophenolic Acid, Atorvastatin Calcium, Pravastatin sodium, Rosuvastatin calcium, Sacubitril and Valsartan, Liothyronine sodium, Prazosin hydrochloride, Aminocaproic Acid, Tacrolimus
- Active ingredients
- Everolimus, Lenalidomide, Dasatinib, Simvastatin, Eltrombopag olamine, Labetalol hydrochloride, Mycophenolate sodium, Atorvastatin calcium trihydrate, Pravastatin sodium, Rosuvastatin calcium, Sacubitril, Valsartan
- NDC labeler codes
- 70377
- Strengths
- Liraglutide 6 mg/mL; Everolimus 5 mg/1; Mycophenolate sodium 180 mg/1; Mycophenolate sodium 360 mg/1; Eltrombopag olamine 12.5 mg/1; Eltrombopag olamine 25 mg/1; Eltrombopag olamine 50 mg/1; Eltrombopag olamine 75 mg/1; Tofacitinib citrate 11 mg/1; Dapagliflozin 2,3-butanediol monohydrate 5 mg/1; Dapagliflozin 2,3-butanediol monohydrate 10 mg/1; Sertraline hydrochloride 150 mg/1; Sertraline hydrochloride 200 mg/1; Everolimus 2 mg/1; Everolimus 3 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Sacubitril 97 mg/1
- Dosage forms
- Tablet, Film coated, Capsule, Tablet, Tablet, Delayed release, Tablet, For suspension, Injection, Powder, Lyophilized, For solution, Suspension, Capsule, Delayed release, Tablet, Film coated, Extended release, Injection, Injection, Solution, Injection, Solution, Concentrate, Powder, For suspension, Solution
- Routes
- Oral, Intravenous, Subcutaneous
- Drug classes (FDA established)
- Kinase Inhibitor, HMG-CoA Reductase Inhibitor, mTOR Inhibitor Immunosuppressant, Thalidomide Analog, Thrombopoietin Receptor Agonist, beta-Adrenergic Blocker, Antimetabolite Immunosuppressant, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, l-Triiodothyronine, alpha-Adrenergic Blocker, Antifibrinolytic Agent, Calcineurin Inhibitor Immunosuppressant, Sodium-Glucose Cotransporter 2 Inhibitor, GLP-1 Receptor Agonist, Serotonin Reuptake Inhibitor, Echinocandin Antifungal, Potassium-sparing Diuretic, Pyrimidine Synthesis Inhibitor, Proton Pump Inhibitor, Janus Kinase Inhibitor, Catecholamine, Nitrofuran Antibacterial, Lipopeptide Antibacterial, Anti-epileptic Agent, Sphingosine 1-phosphate Receptor Modulator, Histamine-2 Receptor Antagonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 192
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Eltrombopag | Eltrombopag olamine 12.5 mg/1 | Tablet, Film coatedOral | 70377-183 | 70377-0183-11 | — |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 25 mg/1 | Tablet, Film coatedOral | 70377-184 | 70377-0184-1170377-0184-12 | — |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 50 mg/1 | Tablet, Film coatedOral | 70377-185 | 70377-0185-1170377-0185-1270377-0185-13 | — |
| Eltrombopageltrombopag olamine | Eltrombopag olamine 75 mg/1 | Tablet, Film coatedOral | 70377-186 | 70377-0186-1170377-0186-12 | — |
| Tofacitinib XRtofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | 70377-057 | 70377-0057-11 | — |
| Dapagliflozin | Dapagliflozin 2,3-butanediol monohydrate 5 mg/1 | Tablet, Film coatedOral | 70377-023 | 70377-0023-1170377-0023-12 | — |
| Dapagliflozin | Dapagliflozin 2,3-butanediol monohydrate 10 mg/1 | Tablet, Film coatedOral | 70377-024 | 70377-0024-1170377-0024-12 | — |
| Liraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | 70377-094 | 70377-0094-5270377-0094-53 | — |
| Liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | 70377-095 | 70377-0095-5270377-0095-53 | — |
| Sertraline HClsertraline hydrochloride | Sertraline hydrochloride 150 mg/1 | CapsuleOral | 70377-128 | 70377-0128-11 | — |
| Sertraline HClsertraline hydrochloride | Sertraline hydrochloride 200 mg/1 | CapsuleOral | 70377-129 | 70377-0129-11 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | 70377-090 | 70377-0090-1170377-0090-23 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | 70377-091 | 70377-0091-1170377-0091-23 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | 70377-092 | 70377-0092-1170377-0092-23 | — |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | 70377-031 | 70377-0031-1170377-0031-1270377-0031-13+1 more | — |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | 70377-032 | 70377-0032-1170377-0032-1270377-0032-13+1 more | — |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | 70377-033 | 70377-0033-1170377-0033-1270377-0033-13+1 more | — |
| Norepinephrine Bitartrate | Norepinephrine bitartrate 1 mg/mL | Injection, Solution, ConcentrateIntravenous | 70377-121 | 70377-0121-12 | — |
| Everolimus | Everolimus .25 mg/1 | TabletOral | 70377-069 | 70377-0069-1170377-0069-12 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | 70377-070 | 70377-0070-1170377-0070-21 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | 70377-071 | 70377-0071-1170377-0071-12 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | 70377-112 | 70377-0112-1170377-0112-21 | — |
| Micafungin | Micafungin sodium 10 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70377-075 | 70377-0075-91 | — |
| Micafungin | Micafungin sodium 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70377-076 | 70377-0076-91 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 70377-049 | 70377-0049-1270377-0049-13 | — |
| Lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 70377-050 | 70377-0050-1270377-0050-13 | — |
| Lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 70377-051 | 70377-0051-1270377-0051-13 | — |
| Lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 70377-052 | 70377-0052-1170377-0052-12 | — |
| Lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 70377-053 | 70377-0053-1170377-0053-12 | — |
| Lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 70377-054 | 70377-0054-1170377-0054-12 | — |
| Dasatinib | Dasatinib 20 mg/1 | Tablet, Film coatedOral | 70377-083 | 70377-0083-11 | — |
| Dasatinib | Dasatinib 50 mg/1 | Tablet, Film coatedOral | 70377-084 | 70377-0084-11 | — |
| Dasatinib | Dasatinib 70 mg/1 | Tablet, Film coatedOral | 70377-085 | 70377-0085-11 | — |
| Dasatinib | Dasatinib 80 mg/1 | Tablet, Film coatedOral | 70377-086 | 70377-0086-11 | — |
| Dasatinib | Dasatinib 100 mg/1 | Tablet, Film coatedOral | 70377-087 | 70377-0087-11 | — |
| Dasatinib | Dasatinib 140 mg/1 | Tablet, Film coatedOral | 70377-088 | 70377-0088-11 | — |
| Triamterene | Triamterene 50 mg/1 | CapsuleOral | 70377-138 | 70377-0138-1170377-0138-12 | — |
| Triamterene | Triamterene 100 mg/1 | CapsuleOral | 70377-139 | 70377-0139-1170377-0139-12 | — |
| Labetalol Hydrochloride | Labetalol hydrochloride 400 mg/1 | Tablet, Film coatedOral | 70377-063 | 70377-0063-1170377-0063-1270377-0063-13 | — |
| Nitrofurantoin | Nitrofurantoin 25 mg/5mL | SuspensionOral | 70377-118 | 70377-0118-31 | — |
| Daptomycin | Daptomycin 500 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70377-093 | 70377-0093-91 | — |
| Mycophenolic Acid | Mycophenolate sodium 180 mg/1 | Tablet, Delayed releaseOral | 70377-126 | 70377-0126-11 | — |
| Mycophenolic Acid | Mycophenolate sodium 360 mg/1 | Tablet, Delayed releaseOral | 70377-127 | 70377-0127-11 | — |
| Oxcarbazepine | Oxcarbazepine 60 mg/mL | SuspensionOral | 70377-117 | 70377-0117-11 | — |
| Fingolimod | Fingolimod hydrochloride .5 mg/1 | CapsuleOral | 70377-019 | 70377-0019-1170377-0019-21 | — |
| Liothyronine sodium | Liothyronine sodium 5 ug/1 | TabletOral | 70377-114 | 70377-0114-1170377-0114-1270377-0114-13 | — |
| Liothyronine sodium | Liothyronine sodium 25 ug/1 | TabletOral | 70377-115 | 70377-0115-1170377-0115-1270377-0115-13 | — |
| Liothyronine sodium | Liothyronine sodium 50 ug/1 | TabletOral | 70377-116 | 70377-0116-1170377-0116-1270377-0116-13 | — |
| Famotidine | Famotidine 40 mg/5mL | Powder, For suspensionOral | 70377-113 | 70377-0113-11 | — |
| Teriflunomide | Teriflunomide 7 mg/1 | Tablet, Film coatedOral | 70377-017 | 70377-0017-1170377-0017-91 | — |
Biocon Pharma Inc.: common questions
- What is Biocon Pharma Inc.'s NDC labeler code?
- 70377. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Biocon Pharma Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.